[Federal Register Volume 68, Number 132 (Thursday, July 10, 2003)]
[Notices]
[Pages 41138-41147]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-17436]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04012]


HIV Prevention Projects; Notice of Availability of Funds

    Application Deadline: October 6, 2003.

A. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a) and 317 (k)(2) of 
the Public Health Service Act, 42 U.S.C. 241 and 42 U.S.C. section 
247b(k)(2), 45 CFR part 92. The Catalog of Federal Domestic Assistance 
number is 93.943.

B. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2004 funds for cooperative agreement 
programs for HIV prevention. This program addresses the ``Healthy 
People 2010'' priority area of HIV infection and the goals of CDC's HIV 
Prevention Strategic Plan Through 2005.
    The overall goal of the strategic plan is to reduce the number of 
new HIV infections in the United States from an estimated 40,000 to 
20,000 per year, focusing particularly on reducing the disproportionate 
impact of HIV infection in racial, ethnic minority populations.
    The majority of transmission of HIV is by persons unaware of their 
infection; one quarter of the people in the United States who are 
infected with HIV do not yet know they are infected. Knowing their HIV 
status would allow these people to receive the benefits of improved 
treatment and care, as well as ongoing prevention services that can 
prevent infection of others.
    CDC is refocusing some HIV prevention activities to reduce the 
number of new HIV infections in the United States (Advancing HIV 
Prevention: New Strategies for a Changing Epidemic--United States, MMWR 
2003; 52(15): 329-332). CDC is doing so by putting more emphasis on 
counseling, testing, and referral for the estimated 180,000 to 280,000 
persons who are unaware of their HIV infection; partner notification, 
including partner counseling and referral services; and prevention 
services for persons living with HIV to help prevent further 
transmission once they are diagnosed with HIV. In addition, since 
perinatal HIV transmission can be prevented, CDC is strengthening 
efforts to promote routine, universal HIV screening as a part of 
prenatal care. All of this will be accomplished through four 
strategies: (1) Making HIV screening a routine part of medical care; 
(2) creating new models for diagnosing HIV infection, including the use 
of rapid testing; (3) improving and expanding prevention services for 
people living with HIV; and, (4) further decreasing perinatal HIV 
transmission.

Performance Goals

    The goals of this program are to assist public health departments 
to decrease transmission of HIV by:
    1. Decreasing the number of persons at high risk for acquiring or 
transmitting HIV infection by delivering targeted, sustained, and 
evidence-based HIV prevention interventions, including prevention of 
perinatal HIV transmission.
    2. Increasing, through voluntary counseling and testing, the 
proportion of HIV-infected people who know they are infected, focusing 
particularly on populations with high rates of undiagnosed HIV 
infection by incorporating the new HIV rapid test

[[Page 41139]]

where applicable, by reconfiguring counseling and testing resources to 
increase the efficiency of such services, by increasing the number of 
providers who routinely provide HIV screening in health care settings, 
and by increasing the number of partners who receive partner 
counseling, testing, and referral services.
    3. Increasing the proportion of HIV-infected people who are linked 
to appropriate prevention, care, and treatment services.
    4. Strengthening the capacity of health department and community-
based organizations to implement effective HIV prevention programs and 
to evaluate them.
    To ensure quality programs and to measure progress, applicants are 
required to report on a core set of indicators appropriate for their 
program activities. Each project area will set their own annual target 
level of performance for each indicator.
    Project areas are accountable for achieving the target levels of 
performance established in their plans. If a project area fails to 
achieve their target, CDC will work with the grantee to determine what 
steps can be taken to improve performance. CDC actions could include 
technical assistance, placing conditions or restrictions on the award 
of funds, or with chronic failure to improve, a reduction in funds.

C. Eligible Applicants

    Applications may be submitted by health departments of states and 
their bona fide agents that currently receive CDC HIV prevention funds 
under Program Announcement 99004 (HIV Prevention Projects). This 
includes the 50 states, six cities (Chicago, Houston, Los Angeles, New 
York, Philadelphia, and San Francisco), the District of Columbia, 
Puerto Rico, and the Virgin Islands. United States Affiliated Pacific 
Island jurisdictions will be funded under a separate program 
announcement.
    For the five states in which there is a CDC directly funded city 
(Chicago, Houston, Los Angeles, New York, Philadelphia, and San 
Francisco), the application must be developed and submitted by a 
coalition of the state and directly funded city health department(s) to 
ensure continuity of services. Either the state or directly funded city 
may submit the application, but only one application may be submitted 
from California, Illinois, New York, Pennsylvania, and Texas. Proof of 
formal collaboration between the state and city is required in the 
application from these jurisdictions.
    Eligible recipients for additional HIV Perinatal Transmission 
Prevention funding must have reported at least 150 cases of perinatally 
acquired AIDS (cumulative) by December 31, 2001 or have Survey of 
Childbearing Women seroprevalence rates in 1994 of greater than or 
equal to 2.0/1000. The following areas meet these criteria: California, 
Connecticut, Delaware, Florida, Georgia, Illinois, Louisiana, Maryland, 
Massachusetts, New Jersey, New York, Pennsylvania, Puerto Rico, South 
Carolina, Texas, and Washington, DC.


    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

D. Funding

Availability of Funds

    Approximately $275,000,000 is available in FY 2004 to fund 59 
awards. Award amounts for each project area will be comparable to 
previous year's funding.
    In addition, approximately $6,300,000 is available for those 
jurisdictions eligible for HIV Perinatal Transmission Prevention 
project funding. Eligible applicants for perinatal funds should submit 
a separate budget in addition to the budget for core services.
    It is expected that the awards will begin on or about January 1, 
2004 and will be made for a 12-month budget period within a five-year 
project period. Funding estimates may change.
    Continuation awards within an approved project period will be made 
based on satisfactory progress as evidenced by successfully 
implementing required recipient activities, meeting annual targets for 
program indicators, and submitting required reports. Continuation 
awards are subject to the availability of funds.

Direct Assistance

    You may request federal personnel, equipment, or supplies as direct 
assistance, in lieu of a portion of financial assistance.

Use of Funds

    Funds may not be used to supplant state or local health department 
funds available for HIV prevention.
    The use of funds should be consistent with the jurisdiction's 
Comprehensive HIV Prevention Plan.
    These funds may not be used to provide direct patient medical care, 
e.g., ongoing medical management and provision of medications, except 
for STD treatment related to HIV prevention when approved by CDC.
    Carryover funds are available only from the previous budget period. 
The request and use of carryover funds from the previous year must be 
consistent with the priorities outlined in the jurisdiction's 
Comprehensive HIV Prevention Plan. Carryover funds are not available 
after the end of the project period.

Recipient Financial Participation

    Recipient financial participation is not required for this program.

E. Program Requirements

    In conducting activities to achieve the purpose of this program 
announcement, the recipient will be responsible for all the activities 
under section 1, below. CDC will be responsible for conducting the 
activities under section 2, below.

1. Recipient Activities

    A comprehensive HIV prevention program that includes the following 
components:
    a. HIV prevention community planning;
    b. HIV prevention activities;
    (1) HIV prevention counseling, testing, and referral services 
(CTR);
    (2) Partner notification, including partner counseling and referral 
services (hereafter known as PCRS) with strong linkages to prevention 
and care services;
    (3) Prevention for HIV-infected persons;
    (4) Health education and risk reduction (HE/RR) activities;
    (5) Public information programs; and,
    (6) Perinatal transmission prevention
    c. Quality assurance;
    d. Evaluation of major program activities, interventions, and 
services, including data collection on interventions and clients 
served;
    e. Capacity-building activities;
    f. Sexually Transmitted Disease (STD) prevention activities;
    g. Collaboration and coordination with other related programs;
    h. Laboratory support; and,
    i. HIV/AIDS epidemiologic and behavioral surveillance.

2. CDC Activities

    a. Provide consultation and technical assistance (TA) to health 
departments in all aspects of their comprehensive HIV prevention 
program, including the community planning process and program 
evaluation activities;
    b. Work with state and local health departments to assess training 
needs and provide training to managers, supervisors, and staff of CTR, 
outreach, or other prevention programs, either

[[Page 41140]]

directly or through its network of TA providers and STD/HIV prevention 
training centers;
    c. Disseminate current information, including best practices, in 
all areas of HIV prevention; facilitate the adoption and adaptation of 
effective intervention models through workshops, conferences, and 
written materials; and provide TA in the development and evaluation of 
new or innovative prevention models;
    d. Develop intervention and program evaluation guidelines and 
program monitoring systems (including indicators);
    e. Facilitate coordination of activities among other CDC programs, 
health departments, community planning groups, directly-funded 
community-based organizations (CBOs), national capacity-building 
assistance (CBA) providers, and with care providers and recipients of 
Ryan White CARE Act funds; and,
    f. Monitor progress in achieving target levels of performance for 
each core indicator, including those for community planning, and take 
appropriate steps when target levels of performance are not met.

F. Application Content

    The Program Announcement title and number must appear in the 
application. Follow the instructions and outline for application 
content in completing your application. Sequentially number all pages 
in the application and attachments, and include a table of contents 
reflecting major categories and corresponding page numbers. Submit the 
original and two copies of the application, unstapled and unbound. 
Provide only those attachments directly relevant to this application. 
All materials must be single spaced, printed in unreduced 12-point 
font, on eight and a half by eleven paper, with at least one margins 
and printing on one side only.
    This section describes program requirements and asks you to 
describe how you will address the requirements. It also lists core 
program indicators to measure program success. Program indicators must 
be objective and quantitative, and must measure the intended outcome of 
the program's activities. You are required to report on the base-line 
level for each indicator in your application as well as a one-year 
interim target and a five-year overall target level of achievement. In 
subsequent progress reports, you will be required to report on progress 
in achieving target levels of performance for each core indicator.

1. HIV Prevention Community Planning

    a. All recipients must:
    (1) Adhere to the HIV Prevention Community Planning Guidance (see 
Attachment 1) by ensuring that the following goals are achieved:
    (a) Goal One--Community planning supports broad-based community 
participation in HIV prevention planning.
    (b) Goal Two--Community planning identifies priority HIV prevention 
needs (a set of priority target populations and interventions for each 
identified target population) in each jurisdiction. All jurisdictions 
are required to prioritize HIV-infected persons as the highest priority 
population for appropriate prevention services. Uninfected, high-risk 
populations such as sex or needle-using partners of people living with 
HIV, should be prioritized based on community needs.
    (c) Goal Three--Community Planning ensures that HIV prevention 
resources target priority populations and interventions set forth in 
the Comprehensive HIV Prevention Plan.
    (2) Ensure that the priorities of the Comprehensive HIV Prevention 
Plan are reflected in your funding application to CDC.
    (3) Ensure that adequate funds are provided to support the 
responsibilities of the community planning group.
    (4) Adhere to the health department roles and responsibilities 
identified in the Community Planning Guidance.
    (5) Collect and report community planning data consistent with the 
Community Planning Guidance. Health departments are required to report 
on progress in meeting the target levels of performance for the core 
indicators of community planning as listed below in F1b(2).
    (6) Ensure that the community planning group develops at least one 
Comprehensive HIV Prevention Plan every five years. This jurisdiction-
wide plan should address all HIV prevention activities; the plan should 
inform decisions about how all HIV prevention funds are to be used, 
including federal, state, local and, when possible, private resources. 
These activities include community planning, CTR/PCRS, HE/RR, 
prevention for people living with HIV, capacity-building, evaluation, 
and other health department activities conducted under this program. 
The plan should summarize any regional planning and community planning 
groups into one summary document.
    (a) Ideally, start the new plan as soon as possible to implement 
the strategies in this announcement and plan through approximately 
December 2007. A new plan should be written in 2008, which will guide 
prevention activities during the following five-year funding cycle 
(January 2009--December 2013).
    (b) Update the Comprehensive HIV Prevention Plan annually.
    b. In your application:
    (1) Report on how performance on each of the three community 
planning goals will be sustained or improved over the five-year project 
period of this program announcement.
    (2) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
indicators: (Refer to HIV Prevention Community Planning Guidance, 
Monitoring and Evaluation Section of Attachment 1 for data collection 
tools).
    (a) Proportion of populations most at risk, as documented in the 
epidemiologic profile, that have at least one community planning group 
(CPG) member that reflects the perspective of each population.
    (b) Proportion of key attributes of an HIV prevention planning 
process that CPG membership agreed have occurred.
    (c) Proportion of prevention interventions and supporting 
activities in the health department CDC funding application specified 
as a priority in the Comprehensive HIV Prevention Plan.
    (d) Proportion of health department-funded prevention interventions 
and supporting activities that correspond to priorities specified in 
the Comprehensive HIV Prevention Plan.
    (3) Provide, as an attachment:
    (a) A copy of the community planning group's letter of concurrence, 
concurrence with reservations, or nonconcurrence. This letter must 
describe the method and timeline for the review of this application by 
the community planning group (CPG). Instances of planning group 
nonconcurrence will be evaluated on a case-by-case basis. After 
consultation with the grantee and the CPG, CDC will determine what 
action is appropriate as outlined in the guidance.
    (b) Your new Comprehensive HIV Prevention Plan, or if your 
jurisdiction has developed a supplementary document that updates and 
describes refinements or changes to the most recent Comprehensive HIV 
Prevention Plan, attach only this supplementary document.

2. HIV Prevention Activities

    There are two overall HIV prevention program performance 
indicators. Specify base-line level for the following two overall 
program measures:
    [sbull] Number of newly diagnosed HIV infections.

[[Page 41141]]

    [sbull] Number of HIV/AIDS cases 13-24 years of age diagnosed each 
year.
a. Counseling, Testing, and Referral (CTR) Services
    All jurisdictions must provide counseling, testing, and referral 
services with a focus on diagnosing as many new cases of HIV as 
possible.
    (1) All recipients must:
    (a) Provide CTR services. These services must be consistent with 
the priorities identified in your Comprehensive HIV Prevention Plan and 
CDC's most current CTR guidelines (CDC Revised Guidelines for HIV 
Counseling, Testing, and Referral. MMWR 2001,50 (RR-19); 1-58) and 
should be designed to diagnose as many new HIV infections as possible.
    (b) Provide, unless prohibited by law or regulation, opportunities 
for persons to receive anonymous CTR services.
    (c) Ensure that appropriate CTR services are provided in settings 
most likely to reach persons who are likely to be infected, but unaware 
of their status. This means that CTR services should be provided in 
settings with high HIV prevalence, e.g., greater than one percent or 
the one-year interim target for the jurisdiction (see 2b, below in this 
section). These services should include use of rapid and other test 
technologies where applicable.
    (e) Ensure the provision of test results, particularly to clients 
testing positive.
    (f) Provide support (e.g., financial, technical assistance, 
training, coordination) to both health department and non-health 
department providers to increase the number of persons diagnosed with 
HIV through strengthening current CTR services or creating new 
services. Work with departments of corrections in their jurisdictions 
to encourage and, when appropriate, support routine voluntary HIV 
screening and referral in correctional facilities. Work with hospitals, 
health maintenance organizations, and other medical providers to 
provide routine HIV screening in high prevalence medical settings. Work 
with community-based organizations to develop or strengthen outreach 
into their communities to increase the number of HIV infections 
diagnosed by increasing the number of high-risk persons participating 
in counseling, testing and referral services.
    (h) Collect and report CTR data as will be specified in the new 
Program Evaluation and Monitoring System (PEMS) (approximately January 
2004), including core indicators.
    (i) Encourage opportunities to integrate CTR and STD services.
    (2) In your application:
    (a) Describe your plan to provide CTR services, including:
    [sbull] How you will improve your efforts to identify newly 
infected persons;
    [sbull] How you will improve provision of test results (especially 
positive results),
    [sbull] Your plan for providing and tracking the completion of 
referrals for persons with positive test results;
    [sbull] How you will work with medical care entities to encourage 
and support routine HIV screening in high prevalence settings; and,
    [sbull] How you will support providers of CTR services.
    (b) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicators:
    [sbull] Percent of newly identified, confirmed HIV-positive test 
results among all tests reported by CDC-funded HIV counseling, testing 
and referral sites.
    [sbull] Percent of newly identified, confirmed HIV-positive test 
results returned to clients.
    [sbull] Percent of facilities reporting a prevalence of new HIV-
positive tests equal to or greater than the jurisdiction's target as 
specified in the first indicator immediately above.
b. Partner Counseling and Referral Services (PCRS)
    (1) All recipients must:
    (a) Ensure that PCRS is a high priority within the jurisdiction's 
HIV prevention activities and is so identified in the Comprehensive HIV 
Prevention Plan. These services must be consistent with the most 
current PCRS guidelines. The most current guidance is ``HIV Partner 
Counseling and Referral Services Guidance'' (December 30, 1998).
    (b) Provide PCRS for HIV-infected persons who have been tested 
either anonymously or confidentially in CDC-funded sites. Ideally, PCRS 
should be offered to all persons with positive test results, regardless 
of where they are tested. Make a good faith effort to notify sexual or 
needle sharing partners. Efforts should be documented. Collaborate with 
STD programs and non-health department providers, including community-
based organizations, to provide PCRS.
    (d) Collect and report PCRS data consistent with core data elements 
as will be specified in PEMS, including core indicators.
    (2) In your application:
    (a) Describe your plan to provide PCRS, including how you will 
address provision of PCRS for clients from non-health department 
settings.
    (b) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicators:
    [sbull] Percent of contacts with unknown or negative serostatus who 
receive an HIV test after PCRS notification.
    [sbull] Percent of contacts with a newly identified, confirmed HIV-
positive test among contacts who are tested.
    [sbull] Percent of contacts with a known, confirmed HIV-positive 
test among all contacts.
c. Prevention for HIV-Infected Persons
    (1) All recipients must:
    (a) Provide prevention services to persons infected with HIV/AIDS 
as outlined in the Comprehensive HIV Prevention Plan.
    (b) Develop a plan to provide financial assistance to CBOs and 
other HIV prevention providers (including local health departments) and 
to collaborate with health care providers to provide prevention 
services such as prevention case management(PCM) and prevention 
counseling.
    (c) Work with primary care clinics in the community that serve 
persons with or at risk for HIV to integrate HIV prevention services 
into care and treatment services.
    (d) Collect and report data on prevention for HIV-positives, 
including core indicators, as will be specified in PEMS.
    (2) In your application:
    (a) Describe your plan to provide prevention services for people 
living with HIV/AIDS.
    (b) Describe your plan to provide financial assistance to CBOs and 
other HIV prevention providers (including local health departments) and 
to collaborate with health care providers to provide prevention 
services such as prevention case management (PCM) and prevention 
counseling.
    (c) Describe how you will encourage primary care clinics to 
integrate prevention and care services; and,
    (d) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicators:
    [sbull] Of those enrolled in PCM, proportion of HIV-infected 
persons that completed the intended number of sessions for PCM.
    [sbull] Percent of HIV-infected persons who, after a specified 
period of participation in PCM, report a reduction in sexual or drug 
using risk behaviors or maintain protective behaviors with sero-
negative partners or with partners of unknown status.
d. Health Education and Risk Reduction Services
    (HE/RR)--These include individual, group, community, and structural 
level

[[Page 41142]]

interventions as well as PCM and outreach for high risk HIV negative 
and HIV positive individuals. See glossary for a definition of these 
services.
    (1) All recipients must:
    (a) Develop a plan to provide financial assistance to CBOs and 
other HIV prevention providers (including local health departments) 
consistent with the prioritized populations and interventions 
established in the Comprehensive HIV Prevention Plan.
    (b) Fund providers who provide services that:
    [sbull] Show evidence that their services focus on those most at 
risk of transmitting or acquiring HIV infection, reflecting the 
priorities established in the Comprehensive HIV Prevention Plan and;
    [sbull] Are based on scientific theory, or have evidence of 
demonstrated or probable outcome effectiveness (see CDC's most current 
Compendium of HIV Prevention Interventions with Evidence of 
Effectiveness, 1999);
    [sbull] Are directed by written procedures or protocols;
    [sbull] Are acceptable to and understood by the target population, 
i.e., are culturally appropriate.
    [sbull] Have quality assurance and evaluation procedures in place.
    (c) Collect and report data on HE/RR activities including core 
indicators as will be specified in PEMS.
    (2) In your application:
    (a) Describe your plan to provide financial assistance to 
prevention providers. Explain any instances of non-competitive award of 
CDC funds. Identify existing providers by prioritized populations and 
interventions that are currently funded. Also prepare a separate list 
identifying interventions that will be funded.
    (b) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicators:
    [sbull] Proportion of persons that completed the intended number of 
sessions for each of the following interventions: individual level 
intervention (ILI), group level intervention (GLI), and PCM.
    [sbull] Proportion of the intended number of the target populations 
to be reached with any of the following specific interventions (ILI, or 
GLI, or PCM) who were actually reached.
    [sbull] The mean number of outreach encounters required to get one 
person to access any of the following services: CT, STD screening and 
testing, ILI, GLI or PCM.
e. Public Information Programs
    (1) All recipients must:
    (a) Develop public information programs based on local needs. CPGs 
must be involved in this decision, e.g., indicate in the HIV 
Comprehensive Prevention Plan the need to provide such services.
    (b) Collect and report data on public information activities as 
will be specified in PEMS.
    (2) In your application:
    Complete this section only if you are requesting program funds to 
support public information programs. Describe your public information 
efforts and how they are consistent with your Comprehensive HIV 
Prevention Plan.
f. Perinatal Transmission Prevention
    (1) All recipients must:
    (a) Work with all health-care providers to promote routine, 
universal HIV screening of all of their pregnant patients. The 
Department of Health and Human Services recommends that all pregnant 
women in the United States be tested for HIV infection (Revised 
Recommendations for HIV Screening of Pregnant Women. MMWR. 2001; 50 
(RR19); 59-86 and Advancing HIV Prevention: New Strategies for a 
Changing Epidemic--United States, 2003, MMWR April 18, 2003/52 (15); 
329-332 425).
    (b) Work with organizations and institutions involved in prenatal 
and postnatal care for HIV-infected women to ensure that appropriate 
HIV prevention counseling, testing, and therapies are provided to 
reduce the risk of perinatal transmission.
    (2) All recipients eligible for perinatal transmission prevention 
funding (see eligibility requirements under ``Eligible Applicants'' 
must:
    (a) Conduct perinatal HIV prevention activities to achieve routine, 
universal HIV screening among pregnant women, incorporating the new HIV 
rapid test where applicable.
    (b) Evaluate perinatal HIV prevention programs using the 
``Perinatal HIV Prevention Programs Evaluation Protocol'' in 
collaboration with CDC staff.
    (c) Work with CDC staff and CDC contractors to facilitate the 
collection of data on prenatal HIV testing rates through a 
representative sample of maternal medical records, and disseminate 
findings to local jurisdictions and delivery hospitals.
    (d) Work closely with organizations and institutions involved in 
prenatal and postnatal care for HIV-infected women to ensure that 
proper HIV prevention counseling, testing and therapies are provided 
during prenatal care, delivery, and postnatal care.
    (3) In your application:
    If your project will not receive funding for HIV perinatal 
prevention:
    (a) Describe how you will work with health care providers to 
promote routine, universal HIV screening to their pregnant patients and 
how you will work with organizations and institutions involved in 
prenatal and postnatal care for HIV-infected women to ensure that 
appropriate HIV prevention counseling, testing, and therapies are 
provided to reduce the risk of transmission.
    (b) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicator: Proportion of pregnant women who receive an HIV test 
during pregnancy.
    If your project is eligible for HIV perinatal prevention funding 
(see page 2):
    (a) Describe your current and planned perinatal HIV prevention 
activities.
    (b) Include a budget detailing the planned funding for your 
targeted perinatal HIV prevention programs; using as the amount per 
year the perinatal funding your jurisdiction has received for targeted 
perinatal HIV prevention programs per year since 1999.
    (c) For the five states in which there is a CDC directly funded 
city, provide evidence of formal collaboration between the state and 
city.
    (d) Indicate your willingness to work with CDC staff and to utilize 
a standardized approach to the gathering of HIV screening rates during 
pregnancy based on medical record data, as well as to carry out 
evaluations of your planned targeted perinatal HIV prevention 
activities as detailed in the ``Perinatal HIV Prevention Programs 
Evaluation Protocol.''
    (e) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following core 
program indicators:
    [sbull] Proportion of women who receive an HIV test during 
pregnancy.
    [sbull] Proportion of HIV-infected pregnant women who receive 
appropriate interventions to prevent perinatal transmission.
    [sbull] Proportion of HIV-infected pregnant women whose infants are 
perinatally infected.

3. Quality Assurance

    a. All recipients must:
    Develop, implement, and maintain quality assurance plans in the 
following programmatic areas:
    (1) CTR and PCRS--the following refer to both health department and 
community based programs funded through the health department.

[[Page 41143]]

    (a) Counseling--Conduct routine, periodic assessments to ensure 
that the counseling being provided includes the recommended, essential 
counseling elements (Please reference Attachment 1 for a link to the 
CDC Revised Guidelines for HIV Counseling, Testing, and Referral. MMWR 
2001,50 (RR-19); 1-58). Quality assurance elements may include but are 
not limited to the following components: training and continuing 
education; supervisor observation with feedback to counselors; case 
conferences; counselor or client satisfaction evaluations; or periodic 
evaluation of space, flow, and time concerns.
    (b) HIV Testing--Develop and implement a quality assurance system 
for all CTR and PCRS providers, with special attention to ensuring that 
HIV-positive clients learn their test results. Develop and implement a 
quality assurance system for implementation of HIV rapid testing.
    (c) Referral--Develop and implement a mechanism for assessing the 
proportion of HIV-positive persons referred for additional services who 
complete their referrals. Review data and improve process as necessary.
    (d) PCRS--Develop, implement, and maintain a system to assess the 
PCRS program and improve its function, e.g., improving the percentage 
of persons who receive PCRS, the quality of PCRS interview sessions, 
and the notification of partners.
    (2) HE/RR Activities
    (a) Develop and implement a mechanism to ensure HE/RR activities 
are appropriate, understandable and acceptable for the specific 
populations served.
    (b) Develop and maintain a mechanism to ensure the consistency, 
accuracy, and relevance of information provided to the public through 
local hotlines and other channels, including information about referral 
services.
    (c) Develop or use existing standard procedures or protocols for 
interventions implemented by health departments and their contractors.
    (d) Actively monitor services and programs provided by funded CBOs 
and other contractors to assist in identifying training and technical 
assistance needs and to ensure that interventions are implemented as 
planned and that program objectives are met.
    (e) Use feedback from client satisfaction surveys in assessing the 
services provided, including prevention services for people living with 
HIV/AIDS. Other science-based methods of assessing services provided 
can also be used.
    (3) Policies, Procedures, and Training
    (a) Develop comprehensive written quality assurance policies and 
procedures to ensure that all HIV prevention activities are delivered 
in an appropriate, competent, and sensitive manner.
    (b) Make quality assurance policies and procedures available to all 
program staff (health departments and their contractors).
    (c) Deliver training to all staff providing HIV prevention 
activities, especially those staff providing CTR, PCRS, and HE/RR 
(health departments and their contractors).
    (d) Train all managers (health departments and their contractors) 
to ensure that quality assurance policies and procedures are followed.
    (4) Data Collection--Develop, implement, and maintain a system to 
assess the quality of data collection.
    b. In your application:
    Describe your quality assurance efforts regarding CTR, PCRS, HE/RR, 
data collection, training, procedures, and any other relevant 
programmatic areas for which you have quality assurance plans.

4. Evaluation

    a. All recipients must:
    (1) Conduct program evaluation. Follow the requirements specified 
in PEMS.
    (2) Collect and report data for the core indicators for community 
planning, HIV prevention activities, evaluation, and capacity-building 
as will be specified in PEMS. For each indicator, provide the 
information as specified on the indicator reporting form (see all 
attachments as posted on CDC website).
    (3) Develop and implement an annual evaluation plan to be updated 
each year. The evaluation plan for the first year shall include at a 
minimum, the following topics:
    [sbull] Description of how the minimum data requirements for 
counseling, testing, and referral, financial reporting, community 
planning, and core indicators will be met;
    [sbull] Description of current data collected for program 
evaluation and monitoring and how these data are compatible with (and 
not in place of) the CDC counseling, testing, and referral reporting 
system, financial reporting, community planning, and core indicators;
    [sbull] Current system of data collection and reporting of HIV 
prevention activities including data system specifications and data 
management information systems; and,
    [sbull] Procedures to ensure that data quality and data security 
are consistent with CDC guidelines.
    For subsequent years, develop and implement a comprehensive 
evaluation plan that includes, at a minimum, the above elements and 
addresses the following topics:
    [sbull] Collection of process monitoring data including client-
level information;
    [sbull] Priority prevention activities selected for outcome 
monitoring and the rationale for their selection; and,
    [sbull] Plans for entry and transmission of data on CDC's browser-
based system or plans to make a local system compatible with CDC's 
requirements as outlined in the most current evaluation guidance.
    (4) Identify the prioritized populations and prevention activities 
funded under this cooperative agreement.
    (5) Collect and report data on the following:
    [sbull] Community planning related to the goals outlined in the 
Community Planning Guidance;
    [sbull] Financial and other service agency characteristics (this 
includes information previously reported in budget tables);
    [sbull] HIV prevention services that may be measured through 
client-level data, including but not limited to ILI, GLI, PCM, CTR, 
PCRS, and outreach; and,
    [sbull] Aggregate-level data for interventions including, but not 
limited to health communication and public information as specified in 
the most recent evaluation guidance.
    (6) Collect and report outcome monitoring and evaluation data for 
prioritized populations and prevention activities.
    (7) Collect and report data on prevention of perinatal 
transmission.
    (8) Collect and report data consistent with the CDC requirements to 
ensure client confidentiality and security.
    (9) Collaborate with CDC in assessing the impact of HIV prevention 
activities by participating in special projects upon request, e.g., 
national behavioral surveillance and incidence.
    (10) Use either the CDC data system or compatible local systems to 
report data electronically as specified in the most recent evaluation 
guidance.
    b. In your application:
    (1) Provide a copy of your evaluation plan for community planning 
and process and outcome monitoring and evaluation of HIV prevention 
activities for the first year.
    (2) Provide a description of your local program evaluation and data 
management system functions and specifications and copies of statewide 
uniform data reporting forms, if they exist.
    (3) Specify base-line level, one-year interim target, and a five-
year overall

[[Page 41144]]

target level of performance for the following core program indicators:
    [sbull] Proportion of providers reporting representative process 
monitoring data to the health department in compliance with the CDC 
program announcement;
    [sbull] Proportion of providers reporting representative outcome 
monitoring data to the health department. (Base-line and performance 
targets are not reported until September 2004).

5. Capacity-Building Activities

    a. All recipients must:
    (1) Conduct a capacity-building needs assessment in the 
jurisdiction for the health department, HIV prevention service 
providers, and other prevention agencies/partners including community-
based organizations. This assessment should include the capacity to 
provide outreach testing, PCRS, and prevention for people living with 
HIV. This requirement can be waived if you can show that you have 
completed a capacity building needs assessment within the last year, 
including an assessment of capacity to provide outreach testing, PCRS, 
and prevention for HIV-positive individuals.
    (2) Develop a comprehensive capacity building plan based on the 
assessment.
    (3) Provide capacity-building assistance, based on the capacity 
building needs assessment, to HIV prevention service providers, and 
other prevention agencies and partners. Create linkages with national 
capacity-building assistance providers (CBAs), where necessary and 
appropriate. Capacity-building assistance may include, but should not 
be limited to:
    (a) Strengthening organizational infrastructure, including 
financial management and compliance with grant or contract 
requirements;
    (b) Enhancing the design, implementation, and evaluation of HIV 
prevention interventions,
    (c) Developing community infrastructure, and
    (d) Strengthening HIV prevention community planning.
    (4) Provide capacity-building assistance to staff of health 
department HIV prevention programs and other staff, e.g., counseling 
and testing programs.
    (5) Provide capacity building assistance to CBOs to provide 
outreach testing and PCRS, including the use of rapid tests.
    (6) Improve the capacity of medical providers to provide routine 
HIV testing, including the use of rapid HIV tests.
    (7) Provide capacity-building assistance to design, implement, and 
sustain prevention interventions for persons living with HIV/AIDS and 
other prioritized target populations.
    (8) Collect and report data on capacity-building activities, 
including core indicators as will be specified in PEMS.
    b. In your application:
    (1) Describe your capacity-building activities in the areas listed 
above. Include the plan if already developed.
    (2) Discuss your plans to strengthen your capacity-building 
activities over the five-year project period for this program 
announcement.
    (3) Discuss how you will assess (for the first time, as well as 
update) capacity-building needs throughout the project period.
    (4) Specify base-line level and a one-year interim target and a 
five-year overall target level of performance for the following 
indicator: Proportion of funded providers who have received health 
department supported capacity building assistance specifically 
training/workshops in the design, implementation or evaluation of 
science-based HIV prevention interventions.

6. STD Prevention Activities

    a. All recipients must:
    (1) Support local efforts to identify persons with STDs that may 
facilitate the transmission of HIV infection.
    (a) STD diagnosis is funded primarily through the STD prevention 
cooperative agreement. However, HIV prevention funds can be used to 
augment STD detection services if there is a documented opportunity to 
enhance HIV prevention efforts, e.g., encourage screening for syphilis 
in areas experiencing syphilis outbreaks. CPGs must be involved in this 
decision, e.g., indicate in the Comprehensive HIV Prevention Plan the 
need to provide such services.
    (b) Funds can be used to underwrite the cost of STD treatment when 
it is intended to specifically reduce HIV trasmission, on a case-by-
case basis, upon approval of CDC.
    (c) When feasible, counseling and testing sites should offer STD 
diagnostic services and referrals for STD treatment. This should also 
be encouraged when HIV testing is offered through outreach activities.
    (2) Incorporate STD messages into HIV prevention messages whenever 
appropriate.
    (3) Collaborate with STD programs in providing PCRS.
    b. In your application:
    Describe your plans to collaborate and coordinate with local STD 
prevention efforts, particularly as they relate to HIV prevention 
activities and screening and treatment for STDs.

7. Collaboration and Coordination

    a. All recipients must:
    Coordinate and collaborate with other agencies, organizations, and 
providers to strengthen HIV prevention and care activities and minimize 
duplication of effort in the jurisdiction. Meaningful coordination and 
collaboration efforts are characterized by joint participatory planning 
to address common areas of service need; development of recommendations 
for program planning and implementation; development of relevant policy 
and/or legislative initiatives; identification of specific steps for 
furthering collaborative efforts within definite time-frames; and, 
outcomes that reflect HIV prevention program goals. At a minimum, 
recipients are expected to coordinate and collaborate with the 
following:
    (1) CDC directly funded CBOs
    The Health Department will review the program plan (i.e., proposed 
target population, intervention, number of persons to be served, and 
service location) of those CBOs considered for funding by CDC. The 
health department will review the plans to ensure no duplication of 
effort, to assess consistency of the proposed target population and 
intervention(s) with the HIV Prevention Comprehensive Plan, and to rate 
the past performance with state/city funded programs. Based on this 
review, the health department will provide a letter of support, support 
with conditions, or non-support to CDC. In a letter of support, the 
health department should describe how they will work with the directly 
funded CBO. The Health Department must also invite the directly funded 
CBOs to community planning meetings and include them in health 
department provided training sessions whenever possible or appropriate.
    (2) HIV/AIDS Care Programs
    To ensure early treatment for HIV-positive individuals, as well as 
to coordinate the provision of HE/RR for HIV-positive individuals, 
jurisdictions are encouraged to collaborate with providers and planners 
of care services for persons living with HIV/AIDS, particularly those 
funded by the Health Resources and Services Administration (HRSA) 
through its Ryan White CARE Act programs. These programs include Title 
I Planning Councils; Title II consortia, Special Projects of National 
Significance, HIV/AIDS CBOs, and community groups; Title III Early 
Intervention Services Programs; and, Title IV Programs serving 
children, youth, women and their families. For a list of currently 
funded CARE Act Programs and for more information on

[[Page 41145]]

the Ryan White CARE Act, please go to http://hab.hrsa.gov/.
    (3) Other Programs--Collaboration and coordination should also 
occur with the following:
    [sbull] Substance abuse prevention and treatment programs, 
including state and local substance abuse agencies and community-based 
and other drug treatment or detoxification programs;
    [sbull] Juvenile and adult criminal justice, correctional, and 
parole systems and programs;
    [sbull] American Indian/Alaska Native tribal councils, Tribal 
community-based organizations, Tribal governments, and Indian Health 
Service-funded programs. Where appropriate, representatives from 
American Indian/Alaska Native tribal councils or a local Indian Health 
Board Member (with support of tribal council) should be involved in 
community planning. Where appropriate, provide financial support based 
on priorities established in the Comprehensive HIV Prevention Plan and 
provide capacity building support for HIV prevention programs.
    [sbull] Hepatitis prevention programs--Support local efforts to 
integrate viral hepatitis services into existing public health programs 
serving persons at risk for multiple infections (including HIV, STDs, 
and hepatitis A, B, or C).
    [sbull] When possible, HIV prevention services should include 
screening for hepatitis viruses (e.g., hepatitis A and B in MSM and 
hepatitis B and C in injection drug users) and provide or link those 
needing immunizations for hepatitis A and B to such services. HIV funds 
may be used for hepatitis testing, but not immunizations against 
hepatitis A or B. CPGs must be involved in this decision, e.g., 
indicate in the HIV Comprehensive Prevention Plan the need to provide 
such services.
    [sbull] Collaborate with Hepatitis B Coordinators and Hepatitis C 
Coordinators in your jurisdiction to integrate services where feasible.
    [sbull] TB clinics and programs;
    [sbull] State and local mental health departments and community 
mental heath centers;
    [sbull] Family planning and women's health agencies and programs, 
including providers of service to women in high-risk situations;
    [sbull] State or local education agencies; schools, boards of 
education, universities and schools of public health.
    [sbull] Other community groups, businesses, and faith-based 
organizations.
    b. In your application:
    Describe your plans to collaborate and coordinate with the programs 
and groups listed above. Also, describe the intended outcomes of your 
collaboration and coordination efforts and plan to strengthen these 
activities over the five-year project period.

8. Laboratory Support

    a. All recipients may:
    Use program funds to support the cost of HIV testing for specimens 
obtained via counseling and testing activities, including rapid tests 
and CD4 and viral load tests. Grantees are encouraged to ensure that 
testing laboratories provide tests of adequate quality, report findings 
promptly, and participate in a laboratory performance evaluation 
program for HIV 1 antibody testing. Grantees are encouraged to include 
participation of their public health laboratory in efforts to assure 
laboratory quality, so as to minimize any inaccuracies that may occur 
during specimen collection, testing, or the reporting of laboratory 
tests.
    b. In your application:
    Briefly describe all laboratory support activities funded under 
this announcement, including participation of any laboratory(s) in a 
performance evaluation program for HIV antibody testing, and the use of 
various testing technologies.

9. HIV/AIDS Epidemiologic and Behavioral Surveillance

    a. All recipients must:
    (1) Respond to the surveillance data needs of prevention program 
managers and CPGs. The needs include analysis, interpretation, and 
presentation of surveillance data; preparation of the epidemiologic 
profiles and other reports for use by the CPGs; and other related 
activities that directly improve and support the implementation and 
evaluation of HIV prevention activities. Although the Surveillance 
Cooperative Agreement provides support to jurisdictions to meet 
surveillance needs, funds under this announcement may be used to help 
support unmet HIV/AIDS surveillance activities as described above. CPGs 
must be involved in the decision-making process. Funds may also be used 
to address data gaps or unmet state or local needs for supplemental 
surveillance, HIV incidence surveillance, or behavioral surveillance.
    (2) Collaborate with surveillance programs to collect data needed 
for HIV incidence surveillance efforts.
    (3) In areas participating in CDC's National Behavioral 
Surveillance Program, collaborate with surveillance to assess exposure 
to, utilization of, and effect of HIV prevention programs.
    (4) Collaborate with CDC for surveillance activities.
    b. In your application:
    Complete this section only if you are requesting program funds to 
support this activity. Describe any surveillance activities you expect 
to conduct with support provided through this program announcement.

Additional Information to be Addressed in the Application Content

1. Other Activities
    a. All recipients must:
    Ensure that appropriate health department and community 
representatives attend CDC-sponsored meetings, e.g. the annual 
Community Planning Leadership Summit and mandatory training sessions 
such as training for rapid testing.
    b. In your application:
    (1) Budget funds provided through this cooperative agreement for 
three persons to attend at least three CDC-sponsored three day 
conferences or meetings each year in Atlanta.
    (2) Describe any other planned activities not previously addressed.
2. Summarize Unmet Needs
    In your application, summarize any HIV prevention needs that will 
remain even if the total application is funded. Provide an estimate of 
funds required to meet these needs.
3. Management and Staffing Plan
    a. All recipients must:
    Have the staff and infrastructure to implement the components of a 
comprehensive HIV prevention program for their jurisdiction. Recipients 
must maintain appropriate staffing to fulfill their responsibility to 
provide capacity-building, evaluation, and quality assurance; to 
support the community planning process; to disburse and monitor funds; 
and to support programs and services provided directly by the health 
department or through CBOs.
    b. In your application:
    Describe your management and staffing plan to conduct or support 
the essential components of your comprehensive HIV prevention program. 
Please include an organizational chart that reflects the current 
management structure and a description of the roles, responsibilities 
and relationships of all staff in the program, regardless of funding 
source. Identify the positions supported through this cooperative 
agreement and those funded through other sources, as well as any 
unfunded staffing needs.

[[Page 41146]]

4. Budget Information
    In accordance with Form CDC 0.1246E (www.cdc.gov/od/pgo/forms/01246.pdf), provide a line item budget and narrative justification for 
all requested costs that are consistent with the purpose, objectives, 
and proposed program activities. Within this budget, please provide the 
documentation requested for each cost category:
    a. Line item breakdown and justification for all personnel, i.e., 
name, position title, annual salary, percentage of time and effort, and 
amount requested.
    b. Line item breakdown and justification for all contracts, 
including: (1) Name of contractor, (2) period of performance, (3) 
method of selection (e.g., competitive or sole source), (4) description 
of activities, (5) target population and (6) itemized budget.
    c. Requests for any new Direct Assistance Federal assignees, 
include:
    (1) Justification for request;
    (2) The number of assignees requested;
    (3) A description of the position and proposed duties;
    (4) The ability or inability to hire locally with financial 
assistance;
    (5) An organizational chart and the name of the intended 
supervisor;
    (6) The availability of career-enhancing training, education, and 
work experience opportunities for the assignee(s) and;
    (7) Assignee access to computer equipment for electronic 
communication with CDC.

G. Submission and Deadline

Submission Date, Time, and Address

    Submit the signed original and two copies of CDC 0.1246. Forms are 
available at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) at: 770-488-2700. Application forms can be mailed to you.
    The application must be received by 4 p.m. Eastern time on October 
6, 2003. Submit the application to:
    Technical Information Management--PA 04012, Procurement and Grants 
Office, Centers for Disease Control and Prevention, 2920 Brandywine Rd, 
Room 3000, Atlanta, GA 30341-4146.
    Applications may not be submitted electronically.

CDC Acknowledgement of Application Receipt

    A postcard will be mailed by PGO-TIM, notifying you that CDC has 
received your application.

Deadline

    Your applications will be considered as meeting the deadline if 
they are received before 4 p.m. Eastern Time on the deadline date. 
Applicants sending applications by the United States Postal Service or 
commercial delivery services must ensure that the carrier will be able 
to guarantee delivery of the application by the closing date and time. 
If an application is received after closing due to (1) carrier error 
(i.e., when the carrier accepted the package with a guarantee for 
delivery by the closing date and time) or (2) significant weather 
delays or natural disasters, CDC will consider the application as 
having been received by the deadline upon receipt of proper 
documentation.
    Applications that do not meet the above criteria may not be funded. 
Applicants will be notified of their failure to meet the submission 
requirements.

H. Evaluation Criteria

    All applications will be reviewed for technical acceptability.

I. Other Requirements

Technical Reporting Requirements

    1. Data reports of agency, financial, and HIV interventions 
including but not limited to HIV individual and group level; PCM; 
outreach; health communication/public information; counseling, testing, 
and referral; partner counseling and referral service; and perinatal 
(for eligible areas) activities are required 45 days after the end of 
each quarter or as specified in the most recent evaluation guidance. 
Project areas may request technical assistance to achieve this. Data 
should be submitted electronically directly to the Program Evaluation 
Research Branch. Following this action, please send an electronic 
notification of your data submission to the Grants Management 
Specialist listed in the ``Where to Obtain Additional Information'' 
section of this announcement.
    2. This program requires progress reporting on a semi-annual basis. 
The first semi-annual progress report (Interim progress report) shall 
be due on the 15th of July each year through 2009. This report will 
serve as your non-competing continuation application and must contain 
the following elements:
    a. Current Budget Period Financial Progress.
    b. Base-line and target level for core and optional indicators.
    c. New budget period proposed program activities.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    3. The second semi-annual report, and a Financial Status Report 
(FSR) shall be due April 1st of each year. Specific guidance on what to 
include in this report will be provided at least three months before 
the due date. It should include the following:
    a. Base-line and actual level of performance on core and optional 
indicators.
    b. Current Budget Period Financial Progress.
    c. Additional requested Information.
    4. A final FSR and final progress report will be due on April 1, 
2009.
    5. Submit any newly developed public information resources and 
materials to the CDC National Prevention Information Network (formerly 
the AIDS Information Clearinghouse) so that they can be incorporated 
into the current database for access by other organizations and 
agencies.
    6. Submit any newly developed public information resources and 
materials to the CDC National Prevention Information Network (formerly 
the AIDS Information Clearinghouse) so that they can be incorporated 
into the current database for access by other organizations and 
agencies.
    7. HIV Content Review Guidelines
    a. Submit completed Assurance of Compliance with the Requirements 
for Contents of AIDS-Related Written Materials Form (CDC form--0.1113). 
This form lists the members of your program review panel. The form is 
enclosed with your application kit. You can also download this form 
from the CDC Web site: http://www.cdc.gov/od/pgo/forminfo.htm. Please 
include this completed form with your application. This form must be 
signed by the Project Director and authorized business official. In 
addition, you must certify that your program review panel represents a 
reasonable cross-section of the community in which the program is 
based.
    b. You must also include documentation of approval by the relevant 
program review panel of any HIV educational materials that you or your 
grantees are currently using. Use the enclosed form, Report of 
Approval. If you have nothing to submit, you must complete the enclosed 
form ``No Report Necessary.'' Either the ``Report of Approval'' or ``No 
Report Necessary''

[[Page 41147]]

must be included with all progress reports and continuation requests. 
In addition, using the Report of Approval, you must include a 
certification that accountable state or local health officials 
independently review the federally-funded HIV prevention materials for 
compliance with Section 2500 of the Public Health Service Act and 
approve the use of such materials in their jurisdiction for directly 
and indirectly funded organizations.
    c. Ensure that a web page notice be used for those grantees whose 
web sites contain HIV/AIDS educational information subject to the CDC 
content review guidelines. Contact your project officer for a copy of 
this guidance.
    8. Address your organization's adherence to CDC policies for 
securing approval for CDC sponsorship of conferences. If you plan to 
hold a conference, you must send a copy of the agenda to CDC's Grants 
Management Office.
    9. If you plan to use materials using CDC's name, send a copy of 
the proposed material to CDC's Grants Management Office for approval.


    Note: Send all reports (except for the first item) to the Grants 
Management Specialist identified in the ``Where to Obtain Additional 
Information'' section of this announcement.

    The following additional requirements may be applicable to this 
program. For a complete description of each, see Attachment I as posted 
on CDC Web site.

AR-1 Human Subjects Requirements
    Before a grant or a cooperative agreement involving research can be 
awarded, an institutional committee must certify a review (described in 
45 CFR part 46). Continuing review is also required.
AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372 Review
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
AR-16 Security Clearance Requirement
AR-20 Conference Support
AR-21 Small, Minority, and Women-Owned Business
AR-22 Research Integrity

J. Where to Obtain Additional Information

    For this and other CDC announcements, the necessary applications, 
and associated forms can be found on the CDC home page, http://www.cdc.gov.
    Click on ``Funding Opportunities'' then ``Grants and Cooperative 
Agreements.''
    For general questions about this announcement, contact:
    Technical Information Management, Procurement and Grants Office, 
Center for Disease Control and Prevention, 2920 Brandywine Rd, Atlanta, 
GA 30341-4146, Telephone: 770-488-2700.
    For business management and budget assistance, contact: Carlos 
Smiley, Grants Management Specialist, Procurement and Grants Office, 
Center for Disease Control and Prevention, 2920 Brandywine Rd, Atlanta, 
GA 30341-4146, Telephone: 770-488-2722, E-mail address:[email protected].
    For business management and budge assistance in the territories 
contact: Charlotte Flitcraft, Procurement and Grants Office, Center for 
Disease Control and Prevention, 2920 Brandywine Rd, Room 3000, Atlanta, 
GA 30341-4146, Telephone: 770-488-2632, E-mail address: [email protected].
    For program technical assistance, contact: Robert N. Kohmescher, 
Office of the Director, Division of HIV/AIDS Prevention, Centers for 
Disease Control and Prevention, 1600 Clifton Road, M/S E35, Telephone: 
(404) 639-1914, E-mail address: [email protected].

Sandra R. Manning,
CGFM, Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-17436 Filed 7-9-03; 8:45 am]
BILLING CODE 4163-18-P